Video
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
(Part 2) From ophthalmology’s lockdown to lasting change: The pandemic habits that stuck
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops (Myatro XL)
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Eye care industry leaders meet at White House to discuss tariff implications
Diagnosis and disease evolution of uveitis: A 10-year look back